Related Experiment Video
Updated: May 28, 2026

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
High-risk prostate cancer: value of multi-modality 3T MRI-guided biopsies after previous negative biopsies
Jurgen J Fütterer1, Sadhna Verma, Thomas Hambrock
1Department of Radiology (667), Radboud University Nijmegen Medical Centre, Geert Grooteplein 10, 6500 HB, Nijmegen, The Netherlands. J.Futterer@rad.umcn.nl
Abstract:
Transrectal ultrasound-guided biopsy is the gold standard for prostate cancer detection. The latter detection rates of random systematic TRUS-guided biopsy do not exceed 44%. As a consequence other biopsy methods have been explored. One of these methods is MR-guided biopsy (MRGB), which revealed detection rates of 38-59% after previous negative TRUSGB sessions. For this reason MRGB will probably become more and more applied in daily practice.

